MedTrace Logo

Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients

NCT04608357 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2025-01-20

No results posted yet for this study

Summary

The investigators propose to use clinically validated patient avatar technology ("PDXovo") that can test multiple drugs against patients' cancers to identify the most promising systemic therapy for each individual.

Conditions

Interventions

DIAGNOSTIC_TEST

Needle Core Biopsies

Not an interventional study

Sponsors & Collaborators

  • AFP Innovation Fund

    collaborator OTHER

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • Katarzyna J Jerzak, MD MSc FRCPC · Sunnybrook Health Sciences Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-21
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04608357 on ClinicalTrials.gov